Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Texas Jack Oil & Gas Corp
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Texas Jack Oil & Gas Corp
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Texas Jack Oil & Gas Corp
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Texas Jack Oil & Gas Corp
CIK:
0001598308
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]
Revenue
$ 375
$ 40,196
Revenue-related party
7,000
Cost of revenue
115,681
201,495
Cost of revenue-related party
4,000
Gross profit
(112,306)
(161,299)
Operating expenses
Professional fees
176,174
83,790
Research and development - related party
1,369,097
461,040
Research and development
3,600
20,700
Selling, general and administrative - related party
1,561,000
2,751,704
Selling, general and administrative
963,450
109,358
Total operating expense
4,073,321
3,426,592
Loss from operations
(4,185,627)
(3,587,891)
Other income (expense)
Interest expense
(281,866)
(802,301)
Amortization of debt discount
(687,460)
(163,931)
Loss on related party transfer of intangible assets
(4,480,000)
Total other income (expense)
(969,326)
(5,446,232)
Net loss
$ (5,154,953)
$ (9,034,123)
Basic and Diluted Loss per Common Share
$ (0.05)
$ (0.14)
Weighted average number of common shares outstanding - basic and diluted
93,904,756
65,905,595
v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities
Net loss
$ (5,154,953)
$ (9,034,123)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Loss on related party transfer of intangible assets
4,480,000
Common stock issued for services
1,741,800
2,544,000
Amortization of debt discount
687,460
163,931
Penalties on default of Firstfire Notes
191,400
Interest recorded on compensatory warrants
737,569
Depreciation and amortization
1,164
1,067
Changes in operating assets and liabilities:
(Increase) decrease in prepaid expenses and other assets
7,653
(12,854)
(Increase) decrease in inventory
29,681
(122,466)
Increase (decrease) in accounts payable and accrued expenses
26,011
(127,336)
Increase (decrease) related party payables
501,577
(227,806)
Net cash flows used in operating activities
(1,968,207)
(642,802)
Cash flows used in investing activity
Purchase of equipment
(3,505)
Net cash flows used in investing activity
(3,505)
Cash flows from financing activities
Proceeds from sale of common stock
1,478,870
680,051
Proceeds from convertible promissory notes
538,200
162,000
Payments of convertible promissory notes
(50,000)
(73,000)
Proceeds from promissory notes
75,000
Payments of promissory notes
(70,780)
(15,845)
Proceeds from related party note, net
144,576
Payments of related party note
(2,785)
(266,270)
Net cash flows from financing activities
1,893,505
706,512
Change in cash
(74,702)
60,205
Cash at beginning of period
74,702
14,497
Cash at end of period
74,702
Supplemental disclosure of cash flow information:
Interest paid in cash
11,875
32,680
Income taxes paid in cash
Supplemental disclosure of non-cash transactions:
Common stock issued for conversion of note payable
195,500
132,711
Debt discount recorded for beneficial conversion feature
538,200
145,617
Common stock issued for license agreements
$ 4,480,000
v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2022
Jun. 30, 2021
Current assets:
Cash
$ 74,702
Prepaid expenses and other current assets
20,266
27,918
Inventory, net
29,681
Deferred financing costs
271,814
Total current assets
20,266
404,115
Equipment, net of accumulated depreciation of $2,230 and $1,067
1,274
2,438
Investment in related party common stock
5,000
5,000
Total assets
26,540
411,553
Current liabilities:
Related party note
2,785
Bank overdraft
1,230
Convertible notes payable, net of discount of $0 and $27,460, respectively
690,900
85,000
Notes payable
43,320
Accounts payable and accrued liabilities
173,727
148,946
Related party payables
730,175
228,598
Total current liabilities
1,596,032
508,649
Total liabilities
1,596,032
508,649
Stockholders’ equity (deficit):
Common stock; $0.001 par value, 400,000,000 shares authorized, 115,287,079 and 78,713,899 shares issued and outstanding at June 30, 2022 and 2021, respectively
115,287
78,714
Additional paid-in capital
17,244,206
13,529,861
Common stock payable
8,700
77,061
Retained deficit
(18,937,685)
(13,782,732)
Total stockholders’ equity (deficit)
(1,569,492)
(97,096)
Total liabilities and stockholders’ equity (deficit)
$ 26,540
$ 411,553